426 related articles for article (PubMed ID: 22639166)
1. Immunogene therapy.
Lichtor T; Glick RP
Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
[TBL] [Abstract][Full Text] [Related]
2. Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine.
Lichtor T; Glick RP; O-Sullivan I; Cohen EP
Curr Genomics; 2006 Jun; 7(4):253-261. PubMed ID: 17160140
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
Lichtor T; Glick RP; Lin H; O-Sullivan I; Cohen EP
Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
[TBL] [Abstract][Full Text] [Related]
5. Cancer therapy with DNA-based vaccines.
Cohen EP
Immunol Lett; 2000 Sep; 74(1):59-65. PubMed ID: 10996629
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
Kim TS; Jung MY; Cho D; Cohen EP
Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
Kim TS; Chopra A; O-Sullivan IS; Cohen EP
J Immunother; 2006; 29(3):261-73. PubMed ID: 16699369
[TBL] [Abstract][Full Text] [Related]
8. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine.
Chopra A; Kim TS; O-Sullivan I; Martinez D; Cohen EP
Int J Cancer; 2006 Jun; 118(11):2888-98. PubMed ID: 16380982
[TBL] [Abstract][Full Text] [Related]
11. Immunity to Trop-1, a newly identified breast cancer antigen, inhibits the growth of breast cancer in mice.
Lee BC; Jung MY; Cho D; O-Sullivan I; Cohen EP; Kim TS
Vaccine; 2010 Nov; 28(49):7757-63. PubMed ID: 20887831
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
13. DNA-based vaccines for the treatment of cancer--an experimental model.
Cohen EP
Trends Mol Med; 2001 Apr; 7(4):175-9. PubMed ID: 11286942
[TBL] [Abstract][Full Text] [Related]
14. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP
J Immunol; 1999 Jun; 162(11):6934-41. PubMed ID: 10352316
[TBL] [Abstract][Full Text] [Related]
15. Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice.
O-Sullivan I; Chopra A; Carr J; Kim TS; Cohen EP
Cancer Res; 2008 Apr; 68(7):2463-70. PubMed ID: 18381455
[TBL] [Abstract][Full Text] [Related]
16. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.
Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F
J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574
[TBL] [Abstract][Full Text] [Related]
17. T-regulatory cells are relatively deficient in squamous carcinomas undergoing regression in mice immunized with a squamous carcinoma vaccine enriched for immunotherapeutic cells.
Chopra A; O-Sullivan I; Carr J; Kim TS; Cohen EP
Cancer Gene Ther; 2007 Jun; 14(6):573-82. PubMed ID: 17384578
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice.
Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB
Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377
[No Abstract] [Full Text] [Related]
19. Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategy.
Chopra A; Kim TS; O-Sullivan I; Martinez D; Cohen EP
Int J Cancer; 2006 Jul; 119(2):339-48. PubMed ID: 16477635
[TBL] [Abstract][Full Text] [Related]
20. Novel chemotactic-antigen DNA vaccine against cancer.
Zhang S; Zhang Y
Future Oncol; 2008 Apr; 4(2):299-303. PubMed ID: 18407741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
